Monday, July 27, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
1 free article left this week. A free account gets you 4 a week.Go Pro →
Regulatory

SKINVIVE by JUVÉDERM Gains FDA Approval for Neck Lines—New Indication Expands Filler Market

Allergan's hyaluronic acid microdroplet formulation clears for neck laxity, opening a new anatomical revenue stream for practices.

Image: Inside MedSpa
1-YEAR MOVE
+15%−13%
ABBV▲11.6%
1-year price move by ticker
TickerCompany1-year change
ABBVAbbVie (Allergan Aesthetics)+11.6%

SKINVIVE by JUVÉDERM, Allergan's hyaluronic acid microdroplet injectable, has received FDA clearance for treatment of neck lines and skin laxity. The formulation is designed to improve skin quality through hydration and subtle volumization rather than traditional bolus filler placement. The mechanism relies on precise microdroplet distribution to stimulate collagen remodeling and improve skin elasticity.

FDA approval for neck lines opens a new anatomical revenue stream for practices using hyaluronic acid injectables.

For medspa practices, this approval expands the addressable market beyond the face. Neck and décolletage treatments have historically relied on laser resurfacing, RF microneedling, or off-label filler use. SKINVIVE's FDA clearance legitimizes injectable treatment of this area and creates a new per-syringe revenue opportunity. Practitioners should expect Allergan to bundle SKINVIVE with existing Juvéderm products in loyalty programs (Alle platform) to drive adoption. The indication also appeals to practices seeking to offer comprehensive facial and neck rejuvenation in a single visit.

Source: original report ↗

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/skinvive-juvéderm-neck-lines-fda-approval/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo